Related Experiment Video
Updated: Aug 4, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
[Nature history of amyotrophic lateral sclerosis]
Lei Qiao1, Xiaoguang Li1, Mingsheng Liu1
1Department of Neurology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Objective:
To explore the nature history of amyotrophic lateral sclerosis (ALS) including type at onset, involvement of region, patterns of spread, survival time and prognosis.
Methods:
A total of 86 patients with sporadic ALS underwent follow-ups at 6-month intervals. Symptom appearances were determined by the revised version ALS functional rating scale. The data were analyzed with Kaplan-Meier curves, t test and variance.
Results:
Their median survival time was 33 months. Median survival time with combined type onset (combined-type ALS<1) defined as involvement of two regions within 1 month of initial presentation was 12 months; Median survival time with combined type onset (combined-type ALS 2-3) defined as involvement of two regions within 2-3 months from single-site onset was 19 months. The median survival time with combined type onset was shorter than with single-site onset. The interval from onset to involvement of a second region was correlated significantly with survival. ALS frequently involved anatomically close to regions in a longitudinal manner and rarely skipped more distantly in disease progression. Early manifestations of bulbar symptoms within 1 year and appearance of respiratory symptoms in patients with normally preserved motor neuron function were associated with a worse survival. Nine patients surviving >5 years had a lower limb onset with a relatively younger age of onset.
Conclusion:
The patients with combined type onset, shorter time of interval from onset to involvement of a second region, early involvement of bulbar and respiratory functions are associated with poor prognosis. Lower limb and younger age onset may achieve a better survival.
Related Concept Videos
Cross-bridge Cycle
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson's Disease: Overview
Multiple Sclerosis l: Introduction
Parkinson Disease ll: Pathophysiology
Myasthenia Gravis ll: Pathophysiology

